Physician profile
Rim Halaby
NPI 1710367321
$52,713.36
in general payments reported to CMS, 2019-2025
7 companies · $48K in 2025
The $48K reported for 2025 was more than what 97% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $326 · 2021: $1,829 · 2022: $1,642 · 2023: $172 · 2024: $20.31 · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $48K · Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $47,946.00 |
| Food and Beverage | $663.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $33,829.91 | 2019-2025 | Mitraclip |
| Medtronic, INC. | $16,427.51 | 2021-2025 | Onyx Frontier, Symplicity G3 |
| Edwards Lifesciences Corporation | $1,416.44 | 2021-2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $492.15 | 2019-2025 | Watchman |
| Astrazeneca Pharmaceuticals LP | $230.87 | 2019 | |
| Inari Medical, INC. | $203.45 | 2022 | |
| Philips North America LLC | $113.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rim Halaby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.